EUCTR2017-002723-16-DE进行中（未招募）1 期
Evaluation of the potential anti-malarial effect of ivermectin: a controlled human malaria infection trial
niversitaetsklinikum Tuebingen0 个研究点目标入组 12 人开始时间: 2017年11月23日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Healthy adults aged 18 to 45 years
- •Body mass index 18 - 35
- •Able and willing (in the Investigator’s opinion) to comply with all study requirements
- •Residence in Tuebingen or surroundings for the period of the trial
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 12
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •History of P. falciparum malaria
- •Travel to malaria endemic region before the participation in the study with positive P. falciparum serology at screening.
- •Use of systemic antibiotics with known antimalarial activity within 30 days of study enrolment (e.g. trimethoprim-sulfamethoxazole, doxycycline, tetracycline, clindamycin, erythromycin, fluoroquinolones, or azithromycin)
研究者
相似试验
已完成
不适用
Measuring malaria transmission after drug treatmentInfections and InfestationsMalariaISRCTN11805747ondon School of Hygiene and Tropical Medicine (UK)600
招募中
不适用
Efficacy and Safety of Artemether- Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Selected Upazila of Chittagong Hill Tracts (CHT), BangladeshResistance status of uncomplicated P. falciparum malaria against Artemether-lumefantrineFeveruncomplicated P.falciparum parasiteACTRN12618001569291Ministry of Health and Family Affairs120
进行中（未招募）
1 期
Evaluation of the prophylactic antimalarial activity of a single dose of DSM265 in non-immune healthy adult volunteers by controlled human malaria infection with PfSPZ ChallengeHealthy volunteerscontrolled human malaria infection with PfSPZMedDRA version: 18.1Level: PTClassification code 10025494Term: Malaria prophylaxisSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2014-005510-34-DEMedicines for Malaria Venture
尚未招募
1 期
A study of the plasma concentration-time profile and antimalarial activity of plasma samples collected from healthy Vietnamese volunteers after the administration of artesunate-amodiaquine alone and with methylene blue.Antimalarial drug resistanceInfection - Other infectious diseasesMalariaACTRN12612001298808Australian Army Malaria Institute16
已完成
不适用
Clinical and laboratory assessment of antimalarial drug efficacy in Lao PDR: an open, randomised comparison of artesunate plus mefloquine versus dihydroartemisinin-piperaquine (Artekin) for the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republicncomplicated falciparum malariaInfections and InfestationsMalariaISRCTN32978789niversity of Oxford (UK)220